Delivery Order SPE2DB22D3004-SPE2DB25FQ93D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $1,451.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.64 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) on September 5, 2025, with completion expected by September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,561.94 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of OxyContin ER 40 mg tablets (100-count units). This is a firm fixed-price contract with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100 count) valued at $10,845.48 under a firm fixed-price contract. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $1,796.20. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, representing a single-transaction purchase of pharmaceutical inventory. The contract was competitively awarded without set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order valued at $2,032.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $6,542.62 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 80 mg tablets (100-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,802.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ93DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,060.48 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count packages) on September 26, 2025, with a completion date of September 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies pharmaceutical products to military and veteran healthcare systems. This delivery order represents a task order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains, positioning AmerisourceBergen as a key strategic partner in the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/26/25 |